Ambu ASFRA:547 86 FCF Margin % is 6.61% as of Mar. 2026, which is 19% below its 10-year median of 8.20. GuruFocus rates FRA:547 with a GF Score™ of 86/100 and a GF Value™ of €34.60. Among 815 Medical Devices & Instruments companies, Ambu AS ranks better than 64.66% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Ambu AS's Free Cash Flow for the
three
months ended in Mar. 2026 was €13.9 Mil. Ambu AS's Revenue for the
three
months ended in Mar. 2026 was €210.5 Mil. Therefore, Ambu AS's FCF Margin % for the quarter that ended in Mar. 2026 was 6.61%.
The historical rank and industry rank for Ambu AS's FCF Margin % or its related term are showing as below:
FRA:547'
s FCF Margin % Range Over the Past 10 Years
Min: -10.31 Med: 8.2 Max: 19.62
Current: 6.14
During the past 13 years, the highest FCF Margin % of Ambu AS was 19.62%. The lowest was -10.31%. And the median was 8.20%.
FRA:547's FCF Margin % is ranked better than 64.66% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.03
vs FRA:547: 6.14
Ambu AS FCF Margin % Related Terms
Ambu AS FCF Margin % Historical Data
* Premium members only.
The historical data trend for Ambu AS's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Ambu AS's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ambu AS FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ambu AS's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Ambu AS's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ambu AS (FRA:547) has a FCF Margin % of 6.61% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Ambu AS and its competitors. This is 19% below median its historical median of 8.20. According to the industry distribution chart, Ambu AS ranks #288 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 35.3%.
Is Ambu AS's FCF Margin % too high?
Ambu AS's current FCF Margin % of 6.61% is 19% below median its 10-year median of 8.20. Based on the distribution chart, Ambu AS ranks #288 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Ambu AS has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does Ambu AS's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Ambu AS ranks #288 out of 815 companies for FCF Margin %. This puts Ambu AS in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Ambu AS and its competitors. Ambu AS's current FCF Margin % is 6.61%, which is 19% below median its own 10-year median of 8.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambu AS stock overvalued right now?
Ambu AS (FRA:547) has a current FCF Margin % of 6.61%. The stock's GF Value™ is €34.60, compared to a current price of €15.90 — trading 54% below its estimated fair value. The current FCF Margin % is 6.61%, which is 19% below median its 10-year median of 8.20. Ambu AS's overall GF Score™ is 86/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Ambu AS (FRA:547), the current FCF Margin % is 6.61% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ambu AS (FRA:547) Overvalued in 2026?
Based on GuruFocus' analysis, Ambu AS stock appears to be undervalued.
The current stock price of €15.90 is trading 54% below its estimated GF Value™ of €34.60.
Key valuation signals for FRA:547:
FCF Margin %: 6.61% (19% below median its 10-year median of 8.20)
GF Value™: €34.60 vs. price of €15.90 (54% below fair value)
No single metric tells the full story. See the FRA:547 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ambu AS provides medical technology solutions. The company's business consists of research and development of new solutions, which are then manufactured, marketed, and sold. It operates in two verticals: Endoscopy Solutions and Anesthesia & Patient Monitoring, with the majority of revenue being generated from the Endoscopy Solutions business. Geographical segments include North America, Europe, and the Rest of the World.
86GF Score
Get the complete analysis for FRA:547
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:547 has been successfully added to your 
